Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections

NCT: NCT06887816 · RECRUITING

NCT IDNCT06887816
StatusRECRUITING
Start Date2025-03-12
Completion2029-03

Brief Summary

The aim of the present clinical study, of prospective observational nature with biological study, is to conduct a clinical investigation on the the efficacy of a device coated with bacteriostatic silver coating, with the overall objective of understand whether the device is indeed able to reduce the number of peri-operative and post-operative infections, both early and late.

Frequently Asked Questions

What is Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections?

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections is a clinical trial registered under NCT06887816. Current status: RECRUITING.

What is the status of NCT06887816?

The current status of NCT06887816 (Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections) is: RECRUITING.

When did Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections start?

Efficacy of New Silver-coated Prosthesis in Reducing the Incidence of Periprosthetic Infections started on 2025-03-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑